Overview

The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia

Status:
Enrolling by invitation
Trial end date:
2022-03-15
Target enrollment:
Participant gender:
Summary
Evaluation of the effect of combinatorial treatment of fibromyalgia patients (standard of care + minocycline + N-acetylcysteine (NAC) relative to standard of care on subjective pain measurement Revised Fibromyalgia Impact Questionnaire (FIQR).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
Treatments:
Minocycline